Joseph Buxbaum, PhD, Director of the Seaver Autism Center for Research and Treatment at Mount Sinai School of Medicine is the figurehead of this-center study. It is also important to mention that IGF1 is already approved by the Food and …
See the original post:
First drug identified as possible autism treatment
